3 Top Tech Stocks to Buy Right Now
These companies are betting on new tech trends and winning.
Editors' Picks
What You'll Want to Know About Centene's Terrific Q3 Results
Great revenue and earnings growth made investors happy with the health insurer's latest performance.
This Clean Energy Stock Continues to Prove it Can Deliver High-Powered Growth
NextEra Energy Partners' strong third-quarter results keep it on track with its impressive dividend growth plan.
Is Seattle Genetics a Good Biotech Stock to Buy Now?
It's become clear that a heavily criticized acquisition was actually a very smart move.
Recent articles
Roku to Acquire Ad Tech Platform Dataxu
The deal will help grow Roku's ad business as it competes with Hulu for ad dollars.
Quietly, CV Sciences Is Succeeding in a Competitive CBD Market
However, one monstrous hurdle remains.
Why a $399 iPhone Could Give Apple's Sales a Big Boost Next Year
Users who have shunned expensive upgrades might shell out for a newer, cheaper device that can run the latest iOS.
Who Gets a Special Enrollment Period for Medicare Part B?
Signing up late for Part B could cost you. But in some cases, you can sign up later than age 65.
Netflix Bounced Back, but It's Next Quarter That Matters More
The dark days of Q2 are behind the streaming giant, but how dark will Q4 be?
3 Top Energy Stocks to Buy Right Now
Clarity and communication offer compelling reasons for investment.
Trade War Fallout: Texas Instruments Earnings, Sales, and Guidance Plunge in Q3
The chip titan will be fine in the long run, but the next few quarters are full of Chinese potholes.
Will a $48 Billion Global Settlement End U.S. Opioid Crisis Lawsuits?
A settlement in a closely watched Ohio case averted a federal trial and paves the way to a nationwide settlement -- if drug companies shorten their payment timelines.
How Risky Is Care.com?
Red flags arise regarding business practices and leadership turnover.
AssetMark Financial Goes Public in Growing TAMP Market
This newly public company helps independent advisors with key services -- and it's taking market share in an industry niche that's transitioning toward its strength.
Better Buy: Aphria vs. Constellation Brands
Which stock wins in a head-to-head matchup between a leading Canadian cannabis producer and the top premium beer maker?
The 5 Biggest Concerns for U.S. Pot Stocks
Marijuana growing pains aren't limited to the Canadian market.
Taco Bell's Beef Recall Could Be More Serious Than "Tortillapocalypse"
Recurring issues with its suppliers could start causing consumers to question its food.
Earnings: 3 Tech Stocks to Watch This Week
Here's what to watch when PayPal, Microsoft, and Twitter report their latest quarterly results.
The Greatest Dividend Stock That You've Never Heard Of
No publicly traded company has been paying a dividend for a longer period.
Should Boston Beer Investors Worry That It Just Changed the Taste of Its Hard Seltzer?
It's also introducing a hard lemonade-seltzer drink next year.
Is AMC Entertainment a Buy After Announcing Video Streaming Plans?
Shares might look cheap, but paying off debt is a hard thing to do.
Here's Why Biogen's Big Gain Won't Last Long
The reassessment of a failed Alzheimer's disease study looks more like an act of desperation than a clinical triumph.
7 Money-Saving Tips That Actually Work
Boosting your savings doesn't have to be difficult. Try these ideas and see for yourself.
Is Biogen a Buy After the Biggest Biotech Bombshell in Years?
A drug once thought as dead could be rising from the ashes. Does Biogen's shocking news make the stock a buy now?